{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:37:11Z","timestamp":1759333031030,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1016\/s0002-9394(99)00237-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T12:51:09Z","timestamp":1027601469000},"page":"692-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost"],"prefix":"10.1016","volume":"128","author":[{"given":"William C.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas G.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth D.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey B.","family":"Dubiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keri T.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9394(99)00237-8_BIB1","first-page":"48","article-title":"Prostaglandin analogues","volume":"14","author":"Stewart","year":"1996","journal-title":"Ophthalmic Pract"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00061198-199812000-00008","article-title":"Efficacy and safety of timolol solution once daily vs. timolol gel in treating elevated IOP","volume":"7","author":"Stewart","year":"1998","journal-title":"J Glaucoma"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archopht.1997.01100160023003","article-title":"Daily cost of beta-adrenergic blocker therapy","volume":"115","author":"Stewart","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9394(14)76896-5","article-title":"Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma","volume":"111","author":"Mao","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB5","unstructured":"Book SA. Essentials of statistics. New York: McGraw Hill Book Company, 1978:117\u2013122, 205\u2013215."},{"key":"10.1016\/S0002-9394(99)00237-8_BIB6","series-title":"Fundamentals of biostatistics","first-page":"301","author":"Rosner","year":"1982"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB7","series-title":"Nonparametric statistics","first-page":"63","author":"Siegel","year":"1956"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB8","unstructured":"A multi-dose, double-masked, parallel, active-treatment-controlled, multi-clinic study of 0.5% Timoptic-XE and 0.5% Timoptic in patients with elevated intraocular pressure (IOP). Merck & Co, Inc, Blue Bell, Pennsylvania, Internal Report DA-TIMXE10."},{"key":"10.1016\/S0002-9394(99)00237-8_BIB9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0161-6420(88)33204-5","article-title":"Ocular hypotensive efficacy of 0.25% levobunolol instilled once daily","volume":"95","author":"Wandel","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0161-6420(89)32940-X","article-title":"A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatment","volume":"96","author":"Rakofsky","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0002-9394(14)76213-0","article-title":"Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure","volume":"112","author":"Silverstone","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0002-9394(86)90823-8","article-title":"Glaucoma treatment with once-daily levobunolol","volume":"101","author":"Wandel","year":"1986","journal-title":"Am J Ophthalmol"},{"issue":"suppl 4","key":"10.1016\/S0002-9394(99)00237-8_BIB13","first-page":"S558","article-title":"Comparison of once daily levobunolol 0.5% versus timolol XE 0.5% for the control of intraocular pressure and patient comfort. ARVO abstract","volume":"38","author":"Cantor","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB14","first-page":"142","article-title":"Systemic beta-blockade with once daily Betimol\u2122 or Timoptic-XE\u2122","volume":"127","author":"Stewart","year":"1999","journal-title":"J Ocul Pharm Ther"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-197601040-00001","article-title":"Clinical pharmacokinetics of \u03b2-adrenoreceptor blocking drugs","volume":"1","author":"Johnsson","year":"1976","journal-title":"Clin Pharmacokine"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bjo.78.12.899","article-title":"Additive effect of latanoprost, a prostaglandin F2\u03b1 analogue, and timolol in patients with elevated intraocular pressure","volume":"78","author":"Rulo","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side-effects of 0.005% latanoprost applied once daily, evening or morning","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(99)00237-8_BIB18","first-page":"1315","article-title":"Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep","volume":"26","author":"Topper","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939499002378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939499002378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:25:13Z","timestamp":1757593513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939499002378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S0002939499002378"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9394(99)00237-8","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[1999,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9394(99)00237-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}